Advertisements

Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University

Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University.....»»

Category: press-releasesSource: businesswireindiaMay 17th, 2017

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers

Boehringer Ingelheim expands collaboration with Vanderbilt University to tackle some of the most difficult-to-treat cancers.....»»

Category: press-releasesSource: businesswireindiaMar 2nd, 2017

Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss

Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss.....»»

Category: press-releasesSource: businesswireindiaNov 29th, 2016

Lupin in pact with Boehringer Ingelheim to market diabetic drug - Livemint

Lupin in pact with Boehringer Ingelheim to market diabetic drug - Livemint.....»»

Category: topSource: googlenewsOct 14th, 2016

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines

Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines.....»»

Category: press-releasesSource: businesswireindiaJul 14th, 2016

Narendra Modi pitches for greater commercial engagement between India, Thailand

Narendra Modi pitches for greater commercial engagement between India, Thailand.....»»

Category: economySource: business-standardJun 17th, 2016

IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function1

IPF patients treated with OFEV® (nintedanib) versus placebo were twice as likely to have improved or stable lung function1.....»»

Category: press-releasesSource: businesswireindiaMay 25th, 2017

Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China

Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China.....»»

Category: press-releasesSource: businesswireindiaMay 16th, 2017

Boehringer Ingelheim: A New World Leader in Animal Health

Boehringer Ingelheim: A New World Leader in Animal Health.....»»

Category: press-releasesSource: businesswireindiaApr 5th, 2017

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases

Boehringer Ingelheim Phase III study now enrolling patients with progressive fibrosing lung diseases.....»»

Category: press-releasesSource: businesswireindiaMar 20th, 2017

Patanjali Ayurved Strengthens Partnership with Ruchi Soya

Patanjali Ayurved Strengthens Partnership with Ruchi Soya.....»»

Category: press-releasesSource: businesswireindiaMar 3rd, 2017

Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments

Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments.....»»

Category: press-releasesSource: businesswireindiaFeb 15th, 2017

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review.....»»

Category: press-releasesSource: businesswireindiaJan 19th, 2017

Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017

Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017.....»»

Category: press-releasesSource: businesswireindiaJan 2nd, 2017

Pharmaceutical sector hiring set for double-digit growth

Pharmaceutical sector hiring set for double-digit growth.....»»

Category: opinionSource: economictimesDec 19th, 2016

The value of conviction in creating a portfolio

The value of conviction in creating a portfolio.....»»

Category: economySource: livemintDec 13th, 2016

Boehringer Ingelheim HCP Survey: Nearly 20% of newly diagnosed lung cancer patients tested for EGFR mutations at risk of missing out on personalised treatments for their disease

Boehringer Ingelheim HCP Survey: Nearly 20% of newly diagnosed lung cancer patients tested for EGFR mutations at risk of missing out on personalised treatments for their disease.....»»

Category: press-releasesSource: businesswireindiaDec 7th, 2016

New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate) in NVAF Patients

New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate) in NVAF Patients.....»»

Category: press-releasesSource: businesswireindiaDec 5th, 2016

Young Turks: Watch the Science story!

Young Turks: Watch the Science story!.....»»

Category: topSource: moneycontrolDec 3rd, 2016

Rupee strengthens marginally against dollar in early trade

Rupee strengthens marginally against dollar in early trade.....»»

Category: economySource: livemintNov 22nd, 2016

Japan, Peru pledge to step up effort for early Trans-Pacific Partnership approval

Japan, Peru pledge to step up effort for early Trans-Pacific Partnership approval.....»»

Category: global-financeSource: business-standardNov 19th, 2016